Clinical trials: Proliferative Vitreoretinopathy
Proliferative Vitreoretinopathy
Isotretinoin for Proliferative Vitreoretinopathy
Proliferative vitreoretinopathy (PVR), or secondary scarring on and around the retina, is an important cause of retinal re-detachment.
- Trial name
- DELIVER (NCT01445028)
- Testing
- Isotretinoin
- Where
- United States
- Volunteers
- 109 people, healthy volunteers welcome
- Sponsor
- Wills Eye